Contraindications
None.
Special warnings
Vaccinate healthy animals only.
Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Not applicable.
Special precautions for the protection of the environment:
Not applicable.
Adverse events
Very rare (< 1 animal / 10 000 animals treated, including isolated reports): | Anaphylaxis1 Injection site swelling2 Injection site reddening3 Elevated temperature4 |
1 Should be treated symptomatically (e.g., epinephrine)
2 Transient, up to 4 cm in diameter, may last up to 5 days.
3 Observed only in association with the injection site swelling.
4 Mean increase of 0.8 °C, lasting up to 20 hours after vaccination.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Following the administration of a 4-fold overdose of vaccine no adverse events other than those described under section "adverse events" have been observed.
Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Boehringer Ingelheim’s Ingelvac CircoFLEX and administered at one injection site.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product except the product mentioned above. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case-by-case basis.
Do not mix with any other veterinary medicinal product, except with Boehringer Ingelheim´s Ingelvac CircoFLEX.
Withdrawal Period
Zero days